Compound used as bruton's tyrosine kinase inhibitor and preparation method and application thereof

A compound, having the structure shown in formula (I) or an isomer, a pharmaceutically acceptable solvate or salt thereof:

• wherein, Y is selected from substituted or unsubstituted aryls or heteroaryls;
• R is selected from substituted or unsubstituted alkenyls or alkynyls;
• M is selected from substituted or unsubstituted N-containing spirocyclic group or N-containing bridged-ring group, and the N atom is attached to a carbonyl group;
• or M is selected from the group shown in formula (II), A is a substituted or unsubstituted spirocyclic group or bridged-ring group, and the amino group is attached to a carbonyl group;